Our GvHD patients were basically on death row too, and 50% completely recovered.
I think it's worth it for sure, as other underlying conditions have been the majority of Covid deaths in aged.
and our pre-clinical in very relevant indications + FDA has already agreed our controls/ dossier is robust
Cynata has manufacturing solution for new covd treatments, page-39
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $42.45M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.5¢ | $9.79K | 41.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3942 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 35000 | 1 |
View Market Depth
| Last trade - 14.18pm 14/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |